Vertex Pharmaceuticals
VRTX
#177
Rank
A$175.33 B
Marketcap
A$683.86
Share price
-0.24%
Change (1 day)
5.38%
Change (1 year)

Market capitalization of Vertex Pharmaceuticals (VRTX)

Market cap: A$175.33 Billion

As of December 2025 Vertex Pharmaceuticals has a market cap of A$175.33 Billion. This makes Vertex Pharmaceuticals the world's 177th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vertex Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025A$175.33 B3.6%
2024A$169.24 B9.97%
2023A$153.89 B41.28%
2022A$108.92 B41.3%
2021A$77.08 B-3.55%
2020A$79.92 B-1.32%
2019A$80.99 B34.94%
2018A$60.02 B23.64%
2017A$48.54 B91.51%
2016A$25.34 B-40.42%
2015A$42.54 B21.22%
2014A$35.09 B80.21%
2013A$19.47 B122.28%
2012A$8.76 B29.69%
2011A$6.75 B-3.75%
2010A$7.01 B-26.41%
2009A$9.53 B56.51%
2008A$6.09 B72.62%
2007A$3.53 B-41.03%
2006A$5.98 B46.38%
2005A$4.08 B270.74%
2004A$1.10 B1.54%
2003A$1.08 B-49.42%
2002A$2.14 B-40.6%
2001A$3.61 B-52.56%
2000A$7.62 B457.24%
1999A$1.36 B11.03%
1998A$1.23 B-3.53%
1997A$1.27 B19.49%
1996A$1.06 B

End of Day market cap according to different sources

On Dec 23rd, 2025 the market cap of Vertex Pharmaceuticals was reported to be:

A$173.50 Billion
by Nasdaq info icon info icon
A$175.33 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
A$231.32 B 31.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$602.17 B 243.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$390.71 B 122.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$164.55 B-6.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$738.32 B 321.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
A$0.67 B-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA